CN Patent

CN109305962B — 一种盐酸达拉他韦的精制方法

Assigned to Yangtze River Pharmaceutical Group Co Ltd · Expires 2022-01-18 · 4y expired

What this patent protects

本发明公开了一种盐酸达拉他韦的精制方法,包括如下步骤:(1)将盐酸达拉他韦粗品加入到甲醇中,55‑65℃溶解;(2)加活性炭在55‑65℃下脱色;(3)过滤,所得滤液升温至55‑65℃,滴加水溶性非质子溶剂A与质子溶剂B的混合溶剂析晶,滴加完毕降至20‑30℃搅拌析晶2h;(4)过滤步骤(3)搅拌析晶后的混合物,所得滤饼真空干燥,即得高纯度盐酸达拉他韦。本发明的方法可有效的去除盐酸达拉他韦粗品中的杂质,产品纯度99.5%以上,异构体杂质以及其他单个杂质均不大于0.1%,精制收率不低于85%,另外本发明的精制方法工艺过程简便,工艺易于工业化生产。

USPTO Abstract

本发明公开了一种盐酸达拉他韦的精制方法,包括如下步骤:(1)将盐酸达拉他韦粗品加入到甲醇中,55‑65℃溶解;(2)加活性炭在55‑65℃下脱色;(3)过滤,所得滤液升温至55‑65℃,滴加水溶性非质子溶剂A与质子溶剂B的混合溶剂析晶,滴加完毕降至20‑30℃搅拌析晶2h;(4)过滤步骤(3)搅拌析晶后的混合物,所得滤饼真空干燥,即得高纯度盐酸达拉他韦。本发明的方法可有效的去除盐酸达拉他韦粗品中的杂质,产品纯度99.5%以上,异构体杂质以及其他单个杂质均不大于0.1%,精制收率不低于85%,另外本发明的精制方法工艺过程简便,工艺易于工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN109305962B
Jurisdiction
CN
Classification
Expires
2022-01-18
Drug substance claim
No
Drug product claim
No
Assignee
Yangtze River Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.